TRIPHENYL PHOSPHITE
General Information
Mainterm | TRIPHENYL PHOSPHITE |
CAS Reg.No.(or other ID) | 101-02-0 |
Regnum |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 7540 |
IUPAC Name | triphenyl phosphite |
InChI | InChI=1S/C18H15O3P/c1-4-10-16(11-5-1)19-22(20-17-12-6-2-7-13-17)21-18-14-8-3-9-15-18/h1-15H |
InChI Key | HVLLSGMXQDNUAL-UHFFFAOYSA-N |
Canonical SMILES | C1=CC=C(C=C1)OP(OC2=CC=CC=C2)OC3=CC=CC=C3 |
Molecular Formula | C18H15O3P |
Wikipedia | triphenyl phosphite |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 310.289 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 6 |
Complexity | 247.0 |
CACTVS Substructure Key Fingerprint | A A A D c c B 4 M A I A A A A A A A A A A A A A A A A A A A A A A A A w Y M A A A A A A A A A B U A A A G g A A A C A A C A S A k A A w B o A A A R C A A C B C A A A C A A A g I A A I i A A G C I g I J i K A E R K A M A A k w B E I i A e A Q A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 27.7 |
Monoisotopic Mass | 310.076 |
Exact Mass | 310.076 |
XLogP3 | None |
XLogP3-AA | 5.5 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 22 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9581 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.6569 |
P-glycoprotein Substrate | Non-substrate | 0.8028 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.6379 |
Non-inhibitor | 0.9724 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8403 |
Distribution | ||
Subcellular localization | Mitochondria | 0.8673 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.7911 |
CYP450 2D6 Substrate | Non-substrate | 0.8386 |
CYP450 3A4 Substrate | Non-substrate | 0.6062 |
CYP450 1A2 Inhibitor | Inhibitor | 0.6302 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.6655 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9336 |
CYP450 2C19 Inhibitor | Inhibitor | 0.6049 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8310 |
CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5418 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.5232 |
Non-inhibitor | 0.8915 | |
AMES Toxicity | Non AMES toxic | 0.9132 |
Carcinogens | Non-carcinogens | 0.6575 |
Fish Toxicity | High FHMT | 0.9006 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9651 |
Honey Bee Toxicity | High HBT | 0.9053 |
Biodegradation | Ready biodegradable | 0.5565 |
Acute Oral Toxicity | II | 0.7621 |
Carcinogenicity (Three-class) | Warning | 0.5878 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -4.8912 | LogS |
Caco-2 Permeability | 0.8800 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.6261 | LD50, mol/kg |
Fish Toxicity | 0.4989 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.8836 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Benzenoids |
Class | Benzene and substituted derivatives |
Subclass | Phenoxy compounds |
Intermediate Tree Nodes | Not available |
Direct Parent | Phenoxy compounds |
Alternative Parents | |
Molecular Framework | Aromatic homomonocyclic compounds |
Substituents | Phenoxy compound - Organic phosphite - Organic oxygen compound - Hydrocarbon derivative - Organooxygen compound - Aromatic homomonocyclic compound |
Description | This compound belongs to the class of organic compounds known as phenoxy compounds. These are aromatic compounds contaning a phenoxy group. |
From ClassyFire